{
  "question_stem": {
    "en": "A 35-year-old woman is hospitalized following a high-speed motor vehicle collision in which she was an unrestrained passenger. She sustained multiple deep lacerations on her extremities, rib contusions, and a complex humerus fracture requiring surgical fixation. Over the next 2 days, the patient's pain is treated with oral morphine every 6 hours and nonsteroidal anti-inflammatory drugs (NSAIDs) every 4 hours. Her pain is controlled with this regimen but recurs if the interval between morphine doses is extended to 8 hours. The patient is otherwise medically stable for discharge. She is concerned about continuing to use narcotics at home to treat her pain because her cousin had a history of opioid use disorder and passed away several years earlier due to an overdose.",
    "zh": "一位35岁的女性因高速机动车碰撞住院，她在事故中未系安全带。她四肢多处深层撕裂伤，肋骨挫伤，以及需要手术固定的复杂肱骨骨折。在接下来的2天里，患者的疼痛采用口服吗啡每6小时一次和非甾体抗炎药（NSAIDs）每4小时一次治疗。她的疼痛通过这种治疗方案得到控制，但如果吗啡给药间隔延长至8小时，疼痛就会复发。患者在其他方面医学状况稳定，可以出院。她担心继续在家中使用麻醉药来治疗疼痛，因为她的表亲有阿片类药物使用障碍的病史，并且几年前因过量用药去世。"
  },
  "question": {
    "en": "Which of the following actions by the physician is most appropriate?",
    "zh": "医生以下哪项措施最合适？"
  },
  "options": {
    "A": {
      "en": "Administer opioids transdermally rather than orally to reduce addiction risk",
      "zh": "经皮给药阿片类药物而非口服以降低成瘾风险"
    },
    "B": {
      "en": "Continue opioid therapy but monitor the patient in the hospital",
      "zh": "继续阿片类药物治疗，但在医院对患者进行监测"
    },
    "C": {
      "en": "Recommend benzodiazepines as they are less likely to result in addiction",
      "zh": "推荐使用苯二氮卓类药物，因为它们不太可能导致成瘾"
    },
    "D": {
      "en": "Recommend NSAIDs only for pain control given the patient's high risk of addiction",
      "zh": "鉴于患者成瘾风险高，仅推荐使用NSAIDs进行疼痛控制"
    },
    "E": {
      "en": "Prescribe a brief course of opioids to be used only for breakthrough pain",
      "zh": "开具短期阿片类药物，仅用于缓解突发性疼痛"
    }
  },
  "correct_answer": "E",
  "explanation": {
    "en": "The patient has acute, post-traumatic pain that is currently controlled with a multimodal regimen including opioids and NSAIDs. She is medically stable for discharge, but she has a significant concern about opioid addiction due to her family history. The goal is to manage her pain effectively while minimizing the risk of long-term opioid use and addiction. \n\n(Choice A) Transdermal opioids, such as fentanyl patches, have similar pharmacodynamic properties to oral opioids and carry a similar risk of misuse and addiction. They are generally not recommended for acute pain in opioid-naive patients. \n\n(Choice B) The patient is medically stable for discharge. Extending hospitalization solely for continued opioid monitoring is not appropriate and represents a misuse of resources. \n\n(Choice C) Benzodiazepines have negligible analgesic effects and also carry a risk of addiction. They are not indicated for pain management. \n\n(Choice D) While NSAIDs are important for pain control, relying solely on them may not be sufficient for this patient's moderate to severe acute pain, especially given the breakthrough pain experienced when morphine doses are extended. Furthermore, the patient's family history, while concerning, does not automatically preclude the judicious use of opioids for acute pain. \n\n(Choice E) Prescribing a brief course of short-acting opioids for breakthrough pain is the most appropriate strategy. This approach acknowledges the patient's need for pain relief while limiting exposure to opioids. For acute pain, especially in opioid-naive patients, opioid therapy should be limited to the first 3-5 days, using the lowest effective dose and duration. Short-acting opioids are preferred for breakthrough pain rather than around-the-clock dosing. This strategy minimizes the risk of long-term opioid use and addiction, aligning with safe opioid prescribing guidelines. \n\nKey Pearls:\n- Prioritize NON-OPIOID interventions for pain management.\n- Use OPIOIDS only when necessary for ACUTE pain and MINIMIZE dose and duration.\n- Limit opioid therapy to <5 days for acute pain.\n- Use LOWEST dose resulting in adequate pain control.\n- Prescribe short-acting opioids ONLY for BREAKTHROUGH pain.\n- Counsel patients on safe use and disposal of unused opioids.",
    "zh": "患者有急性、创伤后疼痛，目前通过包括阿片类药物和NSAIDs在内的多模式治疗方案控制。她医学状况稳定，可以出院，但由于她的家族史，她非常担心阿片类药物成瘾。目标是在有效控制疼痛的同时，最大限度地降低长期使用阿片类药物和成瘾的风险。\n\n（选项A）经皮阿片类药物，如芬太尼贴片，具有与口服阿片类药物相似的药效学特性，并具有相似的误用和成瘾风险。通常不建议用于对阿片类药物不敏感的患者的急性疼痛。\n\n（选项B）患者医学状况稳定，可以出院。仅为了继续监测阿片类药物而延长住院时间是不合适的，并且是对资源的滥用。\n\n（选项C）苯二氮卓类药物的镇痛作用可以忽略不计，并且也存在成瘾风险。它们不适用于疼痛管理。\n\n（选项D）虽然NSAIDs对于疼痛控制很重要，但仅依赖它们可能不足以控制该患者的中度至重度急性疼痛，特别是考虑到当吗啡剂量延长时所经历的突破性疼痛。此外，患者的家族史虽然令人担忧，但并不能自动排除对急性疼痛谨慎使用阿片类药物。\n\n（选项E）开具短期速效阿片类药物用于缓解突破性疼痛是最合适的策略。这种方法承认了患者需要缓解疼痛，同时限制了阿片类药物的暴露。对于急性疼痛，尤其是对阿片类药物不敏感的患者，阿片类药物治疗应限于前3-5天，使用最低有效剂量和持续时间。对于突破性疼痛，优选短效阿片类药物，而不是全天候给药。这种策略最大限度地降低了长期使用阿片类药物和成瘾的风险，与安全的阿片类药物处方指南一致。\n\n关键要点：\n- 优先考虑非阿片类药物干预措施进行疼痛管理。\n- 仅在必要时使用阿片类药物治疗急性疼痛，并尽量减少剂量和持续时间。\n- 将阿片类药物治疗限制在<5天内以治疗急性疼痛。\n- 使用最低剂量达到足够的疼痛控制。\n- 仅为突破性疼痛开具短效阿片类药物。\n- 就安全使用和处理未使用的阿片类药物向患者提供咨询。"
  },
  "summary": {
    "en": "This question tests the understanding of safe opioid prescribing practices for acute pain in a patient with concerns about addiction. It assesses the ability to balance effective pain management with the minimization of risks associated with opioid use, considering patient history and current clinical status.\n\nThe approach to solving this question involves identifying the patient's acute pain needs, recognizing the contraindications and risks associated with each management option, and applying evidence-based guidelines for opioid prescribing, particularly focusing on limiting duration and using opioids only for breakthrough pain when necessary.",
    "zh": "此题考察了对有成瘾担忧的患者的急性疼痛安全阿片类药物处方实践的理解。它评估了在考虑患者病史和当前临床状况的情况下，平衡有效疼痛管理与最大限度地减少与阿片类药物使用相关的风险的能力。\n\n解决此问题的方法包括确定患者的急性疼痛需求，识别与每种管理方案相关的禁忌症和风险，并应用基于证据的阿片类药物处方指南，特别是侧重于限制持续时间，并在必要时仅使用阿片类药物缓解突破性疼痛。"
  },
  "tags": "Opioid prescribing; Acute pain management; Addiction risk; Breakthrough pain; NSAIDs; Benzodiazepines; Pain control; Pharmacology; Patient safety",
  "category": "Psychiatry",
  "question_id": "20736",
  "has_exhibits": false,
  "exhibit_count": 0,
  "exhibit_files": [],
  "folder_path": "C:\\Datas\\usmle\\step1\\clip\\Psychiatry 23\\20736",
  "extracted_at": "2025-11-05T19:50:40.584739",
  "extraction_config": {
    "temperature": 0.1,
    "top_k": 2,
    "prompt_strategy": "standard"
  },
  "translated_at": "2025-11-07T18:55:14.999287",
  "translation_model": "gemini-2.0-flash-lite",
  "embedding_model": "models/embedding-001",
  "embedding_dimension": 768
}